Tag: CAVT
New STORM-PE data show improved functional outcomes with CAVT plus anticoagulation
The 90-day results of the STORM-PE randomised controlled trial (RCT) have demonstrated that pati...
Boston Scientific announces agreement to acquire Penumbra
Boston Scientific and Penumbra today announced the companies have entered into a definitive agre...
TCT 2025: STORM-PE finds mechanical thrombectomy superior to anticoagulation alone
The use of mechanical thrombectomy, specifically computer-assisted vacuum thrombectomy (CAVT) us...
Penumbra’s STORM-PE randomised trial completes enrolment
Penumbra has announced the completion of enrolment in the STORM-PE clinical trial.
The pivot...
